Bredt David

CIK 00020220871 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0002022087

Recent Transactions

27 trades

Exercise/Conversion
Rapport Therapeutics, Inc.$RAPP
Stock Options (Right to Buy)
2026-02-19−6,000→ 88,080 total
Exercise/Conversion
Rapport Therapeutics, Inc.$RAPP
Common Stock
2026-02-19$1.80/sh+6,000→ 393,075 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2026-02-17$28.02/sh−900→ 394,675 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2026-02-17$29.59/sh−2,200→ 387,075 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2026-02-17$28.95/sh−5,400→ 389,275 total
Award
Rapport Therapeutics, Inc.$RAPP
Stock Option (Right to Buy)
2026-02-02+103,000→ 103,000 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2026-01-15$26.83/sh−8,300→ 395,775 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2026-01-15$27.40/sh−200→ 395,575 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-12-31$30.05/sh−6,567→ 404,075 total
Award
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-12-31−18,000→ 410,642 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-12-15$29.95/sh−7,704→ 393,438 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-12-15$30.68/sh−796→ 392,642 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-11-17$24.84/sh−3,156→ 406,486 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-11-17$25.39/sh−5,344→ 401,142 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-10-15$26.16/sh−1,082→ 409,642 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-10-15$25.73/sh−7,418→ 410,724 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-09-15$24.66/sh−3,402→ 418,142 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-09-15$23.88/sh−5,098→ 421,544 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-08-15$14.98/sh−8,300→ 426,842 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-08-15$15.79/sh−200→ 426,642 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-07-15$14.00/sh−8,500→ 435,142 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-06-16$11.00/sh−8,500→ 443,642 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-05-15$9.56/sh−8,500→ 452,142 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-04-15$9.57/sh−8,500→ 460,642 total
Sale
Rapport Therapeutics, Inc.$RAPP
Common Stock
2025-03-14$10.85/sh−8,500→ 469,142 total
Award
Rapport Therapeutics, Inc.$RAPP
Stock Option (Right to Buy)
2025-02-03+100,000→ 100,000 total
Award
Rapport Therapeutics, Inc.$RAPP
Stock Option (Right to Buy)
2024-06-06+28,302→ 28,302 total

Companies

Rapport Therapeutics, Inc.
Chief Scientific Officer
$RAPP

Recent Filings

Address

RAPPORT THERAPEUTICS, INC. 99 HIGH STREET, SUITE 2100

BOSTON, MA, 02110

View on SEC.gov